🚀 VC round data is live in beta, check it out!
Cachet Pharmaceuticals Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cachet Pharmaceuticals and similar public comparables like Farmacias Benavides, GoodRx, Zjamp Group, Genky Drug Stores and more.
Cachet Pharmaceuticals Overview
About Cachet Pharmaceuticals
Cachet Pharmaceutical Co Ltd is a state-owned stock company. Its main business includes: Medicine supply to hospitals, wholesaling of biological products, medical instruments, and traditional Chinese medicines. The Company also involved in pharmaceutical logistics and retail pharmacy chain.
Founded
1997
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$650M
Cachet Pharmaceuticals Financials
Cachet Pharmaceuticals reported last fiscal year revenue of $3B and EBITDA of $65M.
In the same fiscal year, Cachet Pharmaceuticals generated $181M in gross profit, $65M in EBITDA, and $16M in net income.
Cachet Pharmaceuticals P&L
In the most recent fiscal year, Cachet Pharmaceuticals reported revenue of $3B and EBITDA of $65M.
Cachet Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $181M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 6% | XXX | XXX | XXX |
| EBITDA | — | XXX | $65M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 2% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 4% | XXX | XXX | XXX |
| Net Profit | — | XXX | $16M | XXX | XXX | XXX |
| Net Margin | — | XXX | 1% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cachet Pharmaceuticals Stock Performance
Cachet Pharmaceuticals has current market cap of $656M, and enterprise value of $650M.
Market Cap Evolution
Cachet Pharmaceuticals' stock price is $2.25.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $650M | $656M | 1.0% | XXX | XXX | XXX | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCachet Pharmaceuticals Valuation Multiples
Cachet Pharmaceuticals trades at 0.2x EV/Revenue multiple, and 10.0x EV/EBITDA.
Cachet Pharmaceuticals Financial Valuation Multiples
As of March 19, 2026, Cachet Pharmaceuticals has market cap of $656M and EV of $650M.
Equity research analysts estimate Cachet Pharmaceuticals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cachet Pharmaceuticals has a P/E ratio of 40.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $656M | XXX | $656M | XXX | XXX | XXX |
| EV (current) | $650M | XXX | $650M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 10.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 6.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.6x | XXX | XXX | XXX |
| P/E | — | XXX | 40.5x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 3.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cachet Pharmaceuticals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cachet Pharmaceuticals Margins & Growth Rates
Cachet Pharmaceuticals' revenue in the last fiscal year declined by (19%).
Cachet Pharmaceuticals Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (19%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (44%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 3% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cachet Pharmaceuticals Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Farmacias Benavides | XXX | XXX | XXX | XXX | XXX | XXX |
| GoodRx | XXX | XXX | XXX | XXX | XXX | XXX |
| Zjamp Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Genky Drug Stores | XXX | XXX | XXX | XXX | XXX | XXX |
| JZJ Chain Drugstore | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cachet Pharmaceuticals M&A Activity
Cachet Pharmaceuticals acquired XXX companies to date.
Last acquisition by Cachet Pharmaceuticals was on XXXXXXXX, XXXXX. Cachet Pharmaceuticals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cachet Pharmaceuticals
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCachet Pharmaceuticals Investment Activity
Cachet Pharmaceuticals invested in XXX companies to date.
Cachet Pharmaceuticals made its latest investment on XXXXXXXX, XXXXX. Cachet Pharmaceuticals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cachet Pharmaceuticals
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cachet Pharmaceuticals
| When was Cachet Pharmaceuticals founded? | Cachet Pharmaceuticals was founded in 1997. |
| Where is Cachet Pharmaceuticals headquartered? | Cachet Pharmaceuticals is headquartered in China. |
| Is Cachet Pharmaceuticals publicly listed? | Yes, Cachet Pharmaceuticals is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Cachet Pharmaceuticals? | Cachet Pharmaceuticals trades under 002462 ticker. |
| When did Cachet Pharmaceuticals go public? | Cachet Pharmaceuticals went public in 2010. |
| Who are competitors of Cachet Pharmaceuticals? | Cachet Pharmaceuticals main competitors are Farmacias Benavides, GoodRx, Zjamp Group, Genky Drug Stores. |
| What is the current market cap of Cachet Pharmaceuticals? | Cachet Pharmaceuticals' current market cap is $656M. |
| What is the current revenue of Cachet Pharmaceuticals? | Cachet Pharmaceuticals' last fiscal year revenue is $3B. |
| What is the current EV/Revenue multiple of Cachet Pharmaceuticals? | Current revenue multiple of Cachet Pharmaceuticals is 0.2x. |
| Is Cachet Pharmaceuticals profitable? | No, Cachet Pharmaceuticals is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.